Better glycaemic control with once-weekly insulin icodec versus once-daily insulin degludec in adults with insulin-naive type 2 diabetes (ONWARDS 3)

被引：0
|
作者：
Lingvay, I. [1 ,2 ]
Asong, M. [3 ]
Desouza, C. [4 ]
Gourdy, P. [5 ,6 ]
Kar, S. [7 ]
Vianna, A. [8 ]
Vilsboll, T. [9 ,10 ]
Vinther, S. [3 ]
Mu, Y. [11 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Endocrinol, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Peter ODonnell Jr Sch Publ Hlth, Dallas, TX 75390 USA
[3] Novo Nordisk AS, Soborg, Denmark
[4] Univ Nebraska Med Ctr, Omaha, NE USA
[5] CHU Toulouse, Toulouse, France
[6] Univ Toulouse 3, INSERM, I2MC, UMR1297, Toulouse, France
[7] Novo Nordisk Serv Ctr India Private Ltd, Bangalore, Karnataka, India
[8] Hosp Nossa Senhora Gracas, Curitiba Diabet Ctr, Dept Endocrine Dis, Curitiba, Parana, Brazil
[9] Univ Copenhagen, Steno Diabet Ctr Copenhagen, Clin Res, Herlev, Denmark
[10] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[11] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Med Ctr 1, Beijing, Peoples R China
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
8
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of once-weekly insulin icodec vs once-daily basal insulin in type 2 diabetes by ethnicity and race: ONWARDS 1-5
    Lingvay, I.
    Bangsgaard, K. O.
    Desouza, C.
    Fragao-Marques, M.
    Navarria, A.
    Vianna, A.
    DIABETOLOGIA, 2024, 67 : S375 - S376
  • [22] Impact of Age on the Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Insulin in Type 2 Diabetes (ONWARDS 1-5)
    Vianna, Andre G. D.
    Desouza, Cyrus
    Laugesen, Christian
    Marques, Mariana Fragao
    Nielsen, Pernille Hojlund
    Shaikh, Shehla S.
    Lingvay, Ildiko
    DIABETES, 2024, 73
  • [23] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with Type 2 diabetes (SUSTAIN 4)
    Aroda, V. R.
    Bain, S. C.
    Cariou, B.
    Piletic, M.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    de Vries, J. H.
    DIABETIC MEDICINE, 2017, 34 : 146 - 146
  • [24] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    DeVries, J. H.
    Bain, S. C.
    Cariou, B.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    Aroda, V. R.
    DIABETOLOGIA, 2016, 59 : S76 - S77
  • [25] CGM in insulin-experienced individuals with type 2 diabetes switched to once-weekly insulin icodec versus once-daily comparators in ONWARDS 2 and 4: post hoc analysis
    Asbjornsdottir, B.
    Bajaj, H. S.
    Lehrskov, L. L.
    Mathieu, C.
    Philis-Tsimikas, A.
    Wang, N.
    Battelino, T.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S398 - S398
  • [26] Efficacy and safety of once-weekly insulin icodec versus once-daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the ONWARDS 1, 2 and 4 trials
    Watada, Hirotaka
    Asbjornsdottir, Bjorg
    Nishida, Tomoyuki
    Nishimura, Rimei
    Yamamoto, Yuiko
    Yamauchi, Toshimasa
    Kadowaki, Takashi
    DIABETES OBESITY & METABOLISM, 2024, 26 (12): : 5882 - 5895
  • [27] Efficacy and safety of once-weekly insulin icodec vs once-daily basal insulin in individuals with type 2 diabetes by kidney function: ONWARDS 1-5
    Cheng, A. Y. Y.
    Rossing, P.
    Benamar, M.
    Laugesen, C.
    Nielsen, P. H.
    Bajaj, H. S.
    DIABETOLOGIA, 2024, 67 : S375 - S375
  • [28] Hypoglycaemia frequency and physiological response to double or triple doses of once-weekly insulin icodec versus once-daily insulin glargine in type 2 diabetes
    Pieber, T. R.
    Arfelt, K. N.
    Cailleteau, R.
    Thomsen, K. M. Due
    Hart, M.
    Mursic, I.
    Svehlikova, E.
    Urschitz, M.
    Haahr, H.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S333 - S333
  • [29] Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
    Philis-Tsimikas, Athena
    Asong, Marisse
    Franek, Edward
    Jia, Ting
    Rosenstock, Julio
    Stachlewska, Karolina
    Watada, Hirotaka
    Kellerer, Monika
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (06): : 414 - 425
  • [30] Improved patient-reported outcomes with once-weekly insulin icodec with a dosing guide app versus once-daily basal insulin analogues in type 2 diabetes (ONWARDS 5)
    Goldenberg, R.
    Benamar, M.
    Carstensen, L.
    Davies, M.
    Donatsky, A. M.
    Franek, E.
    Kellerer, M.
    Polonsky, W.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S397 - S398
12345